Jodie Pope Morrison is President at Tokai Pharmaceuticals Inc (TKAI). They have made 4 open-market trades across 1 company since 2015, most recently 2026-08-25.
CIK 0001618247
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| QTTB | 343,259 | $2.6M |
| KERX | 120,000 | $403K |
| AKBA | 58,619 | $39K |
| TKAI | 57,566 | — |
| Total | $3.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-27 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| QTTB | SELL | 2026-08-25 | 2026-08-27 | $16.56 | $163K | -29.5% | -41.5% | — |
| QTTB | SELL | 2026-02-25 | 2026-02-27 | $4.51 | $45K | +56.0% | +33.6% | +131.2% |
| QTTB | SELL | 2025-12-02 | 2025-12-04 | $3.46 | $156K | -19.1% | -5.3% | +32.9% |
| QTTB | SELL | 2025-08-26 | 2025-08-28 | $1.80 | $19K | +0.6% | +9.6% | +16.4% |
| TKAI | SELL · 10b5-1 | 2015-07-28 | 2015-07-30 | $13.70 | $172K | N/A | N/A | N/A |
| TKAI | SELL · 10b5-1 | 2015-06-26 | 2015-06-30 | $13.77 | $220K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.